Synergetics USA, Inc., formerly Valley Forge Scientific Corp., is a supplier of precision surgical devices. The Company focuses on the surgical disciplines of ophthalmology and neurosurgery. It offers precision engineered disposable and reusable devices, surgical equipment and surgical procedural kits. It also delivers energy modalities for the performance of surgery, including laser energy, ultrasonic energy, radio frequency energy for electro surgery and lesion generation, visible light energy for illumination and simultaneous infusion (irrigation) of fluids into the operative field. Its products include VersaVIT 2.0 Vitrectomy System, Directional II Laser Probe and Pinnacle 360°. It offers its products under the brand names: VersaPACK, Core Essentials, Photon, Solitaire, Volk's and Labtician's, among others. It offers approximately 1,000 separate catalogue items in the vitreoretinal surgical market. It sells its products in approximately 60 countries outside the United States.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Advanced Medical Equipment & Technology - NEC
- Sub-Industry: N/A
- Symbol: NASDAQ:SURG
- CUSIP: N/A
- Web: N/A
- 50 Day Moving Avg: $6.34
- 200 Day Moving Avg: $5.15
- 52 Week Range: $3.18 - $6.74
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: 16.73
- P/E Growth: 0.00
- Net Margins: 7.35%
- Return on Equity: 9.09%
- Return on Assets: 6.45%
- Average Volume: 346,194 shs.
Frequently Asked Questions for Synergetics USA (NASDAQ:SURG)
What is Synergetics USA's stock symbol?
Synergetics USA trades on the NASDAQ under the ticker symbol "SURG."
How were Synergetics USA's earnings last quarter?
Synergetics USA Inc (NASDAQ:SURG) announced its earnings results on Wednesday, October, 14th. The company reported $0.06 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.06. Synergetics USA had a net margin of 7.35% and a return on equity of 9.09%. View Synergetics USA's Earnings History.
Who are some of Synergetics USA's key competitors?
Some companies that are related to Synergetics USA include Thermo Fisher Scientific (TMO), Danaher Corporation (DHR), Boston Scientific Corporation (BSX), Intuitive Surgical (ISRG), Koninklijke Philips N.V. (PHG), Illumina (ILMN), Edwards Lifesciences Corporation (EW), Cerner Corporation (CERN), Agilent Technologies (A), Waters Corporation (WAT), Hologic (HOLX), ResMed (RMD), Varian Medical Systems (VAR), PerkinElmer (PKI), ABIOMED (ABMD), Bruker Corporation (BRKR), Alere (ALR) and Accelerate Diagnostics (AXDX).
How do I buy Synergetics USA stock?
Shares of Synergetics USA can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Synergetics USA's stock price today?
MarketBeat Community Rating for Synergetics USA (NASDAQ SURG)MarketBeat's community ratings are surveys of what our community members think about Synergetics USA and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Synergetics USA stock can currently be purchased for approximately $6.69.
Consensus Ratings for Synergetics USA (NASDAQ:SURG) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for Synergetics USA (NASDAQ:SURG)
(Data available from 7/20/2015 forward)
|Date||Firm||Action||Rating||Price Target||Impact on Share Price||Details|
|9/3/2015||Craig Hallum||Downgrade||Buy -> Hold||N/A|
|9/3/2015||Stephens||Downgrade||Overweight -> Equal Weight||N/A|
Earnings History for Synergetics USA (NASDAQ:SURG)Earnings History by Quarter for Synergetics USA (NASDAQ SURG)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|6/9/2015||Q315||$0.04||$0.05||$19.16 million||$19.38 million||View||N/A|
|3/10/2015||Q215||$0.02||$0.07||$17.60 million||$18.20 million||View||N/A|
|12/10/2014||Q115||$0.02||$0.03||$15.76 million||$16.60 million||View||N/A|
|10/14/2014||Q414||$0.03||$0.06||$17.32 million||$18.00 million||View||Listen|
|6/9/2014||Q314||$0.04||$0.04||$16.50 million||$16.10 million||View||N/A|
|3/6/2014||Q214||$0.03||$0.01||$15.10 million||$15.10 million||View||N/A|
|12/9/2013||Q1||$0.04||$0.04||$15.73 million||$15.50 million||View||Listen|
|10/1/2013||Q413||$0.06||$0.06||$17.01 million||$17.90 million||View||N/A|
|6/10/2013||Q3 2013||$0.03||$0.05||$14.99 million||$16.30 million||View||N/A|
|3/12/2013||Q2 2013||$0.07||$0.05||$16.09 million||$14.06 million||View||N/A|
|12/10/2012||0.05||$0.05||$0.05||$14.37 million||$14.60 million||View||N/A|
|10/1/2012||Q412||$0.08||$0.08||$16.61 million||$16.90 million||View||N/A|
Earnings Estimates for Synergetics USA (NASDAQ:SURG)
Current Year EPS Consensus Estimate: $0.26 EPS
Next Year EPS Consensus Estimate: $0.40 EPS
Dividend History for Synergetics USA (NASDAQ:SURG)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Synergetics USA (NASDAQ:SURG)Insider Trades by Quarter for Synergetics USA (NASDAQ:SURG)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|12/31/2014||Michael Fanning||VP||Sell||5,000||$4.32||$21,600.00|| |
|10/20/2014||David Graeme Thomas||Director||Buy||1,000||$3.37||$3,370.00|| |
|3/26/2014||David Hable||CEO||Buy||3,257||$3.04||$9,901.28|| |
|3/21/2014||David Graeme Thomas||Director||Buy||1,000||$3.07||$3,070.00|| |
|1/3/2014||Michael Fanning||VP||Sell||2,290||$3.47||$7,946.30|| |
|10/16/2013||Jerry L Malis||EVP||Sell||10,000||$4.57||$45,700.00|| |
|10/15/2013||Jerry Malis||EVP||Sell||40,000||$4.55||$182,000.00|| |
|10/11/2013||Michael Fanning||VP||Sell||4,000||$4.67||$18,680.00|| |
|10/10/2013||Jerry Malis||EVP||Sell||50,605||$4.60||$232,783.00|| |
|10/7/2013||Jerry Malis||EVP||Sell||49,395||$4.50||$222,277.50|| |
|3/20/2013||Michael Fanning||VP||Buy||2,000||$3.43||$6,860.00|| |
|3/19/2013||Michael Fanning||VP||Buy||7,300||$3.30||$24,090.00|| |
Headline Trends for Synergetics USA (NASDAQ:SURG)
Latest Headlines for Synergetics USA (NASDAQ:SURG)
Synergetics USA (SURG) Chart for Thursday, July, 20, 2017